169 related articles for article (PubMed ID: 32930785)
1. Intensity-modulated Radiotherapy for Pituitary Somatotroph Adenomas.
Lian X; Shen J; Gu Z; Yan J; Sun S; Hou X; You H; Xing B; Zhu H; Shen J; Zhang F
J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32930785
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Insulin-Like Growth Factor Index and Biologically Effective Dose on Outcomes After Stereotactic Radiosurgery for Acromegaly: Cohort Study.
Graffeo CS; Donegan D; Erickson D; Brown PD; Perry A; Link MJ; Young WF; Pollock BE
Neurosurgery; 2020 Sep; 87(3):538-546. PubMed ID: 32267504
[TBL] [Abstract][Full Text] [Related]
3. Long-term Outcome After Fractionated Radiotherapy for Pituitary Adenoma: The Curse of the Secretory Tumor.
Scheick S; Amdur RJ; Kirwan JM; Morris CG; Mendenhall WM; Roper S; Friedman W
Am J Clin Oncol; 2016 Feb; 39(1):49-54. PubMed ID: 25007040
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic radiosurgery for acromegaly.
Lee CC; Vance ML; Xu Z; Yen CP; Schlesinger D; Dodson B; Sheehan J
J Clin Endocrinol Metab; 2014 Apr; 99(4):1273-81. PubMed ID: 24471574
[TBL] [Abstract][Full Text] [Related]
5. Radiosurgery of growth hormone-producing pituitary adenomas: factors associated with biochemical remission.
Pollock BE; Jacob JT; Brown PD; Nippoldt TB
J Neurosurg; 2007 May; 106(5):833-8. PubMed ID: 17542527
[TBL] [Abstract][Full Text] [Related]
6. Fractionated radiotherapy and radiosurgery in acromegaly: analysis of 352 patients from the German Acromegaly Registry.
Knappe UJ; Petroff D; Quinkler M; Schmid SM; Schöfl C; Schopohl J; Stieg MR; Tönjes A;
Eur J Endocrinol; 2020 Mar; 182(3):275-284. PubMed ID: 31917680
[TBL] [Abstract][Full Text] [Related]
7. Radiation therapy in the multimodal treatment approach of pituitary adenoma.
Becker G; Kocher M; Kortmann RD; Paulsen F; Jeremic B; Müller RP; Bamberg M
Strahlenther Onkol; 2002 Apr; 178(4):173-86. PubMed ID: 12040754
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic radiosurgery for acromegaly: outcomes by adenoma subtype.
Lee CC; Vance ML; Lopes MB; Xu Z; Chen CJ; Sheehan J
Pituitary; 2015 Jun; 18(3):326-34. PubMed ID: 24925503
[TBL] [Abstract][Full Text] [Related]
9. Long-term results of fractionated stereotactic radiotherapy as third-line treatment in acromegaly.
Diallo AM; Colin P; Litre CF; Diallo MM; Decoudier B; Bertoin F; Higel B; Patey M; Rousseaux P; Delemer B
Endocrine; 2015 Dec; 50(3):741-8. PubMed ID: 25956280
[TBL] [Abstract][Full Text] [Related]
10. Postoperative Gamma Knife Radiosurgery for Cavernous Sinus-Invading Growth Hormone-Secreting Pituitary Adenomas.
Kim EH; Oh MC; Chang JH; Moon JH; Ku CR; Chang WS; Lee EJ; Kim SH
World Neurosurg; 2018 Feb; 110():e534-e545. PubMed ID: 29155347
[TBL] [Abstract][Full Text] [Related]
11. Intensity-modulated radiotherapy for cushing's disease: single-center experience in 70 patients.
Lian X; Xu Z; Sun S; Wang W; Zhu H; Lu L; Hou X; Zhang F
Front Endocrinol (Lausanne); 2023; 14():1241669. PubMed ID: 37822603
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of fractionated radiotherapy and stereotactic radiosurgery for pituitary adenomas: long-term results of 125 consecutive patients treated in a single institution.
Kong DS; Lee JI; Lim DH; Kim KW; Shin HJ; Nam DH; Park K; Kim JH
Cancer; 2007 Aug; 110(4):854-60. PubMed ID: 17599761
[TBL] [Abstract][Full Text] [Related]
13. Acromegaly: a single centre's experience of stereotactic radiosurgery and radiotherapy for growth hormone secreting pituitary tumours with the linear accelerator.
Wilson PJ; De-Loyde KJ; Williams JR; Smee RI
J Clin Neurosci; 2013 Nov; 20(11):1506-13. PubMed ID: 23911106
[TBL] [Abstract][Full Text] [Related]
14. Endocrine Remission After Pituitary Stereotactic Radiosurgery: Differences in Rates of Response for Matched Cohorts of Cushing Disease and Acromegaly Patients.
Trifiletti DM; Xu Z; Dutta SW; Quiñones-Hinojosa A; Peterson J; Vance ML; Sheehan JP
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):610-617. PubMed ID: 29678528
[TBL] [Abstract][Full Text] [Related]
15. Long-term results of hypofractionated stereotactic radiotherapy with CyberKnife for growth hormone-secreting pituitary adenoma: evaluation by the Cortina consensus.
Iwata H; Sato K; Nomura R; Tabei Y; Suzuki I; Yokota N; Inoue M; Ohta S; Yamada S; Shibamoto Y
J Neurooncol; 2016 Jun; 128(2):267-75. PubMed ID: 26961771
[TBL] [Abstract][Full Text] [Related]
16. Feasibility and outcome of re-irradiation in the treatment of multiply recurrent pituitary adenomas.
Verma J; McCutcheon IE; Waguespack SG; Mahajan A
Pituitary; 2014 Dec; 17(6):539-45. PubMed ID: 24272035
[TBL] [Abstract][Full Text] [Related]
17. Hypopituitarism after stereotactic radiosurgery for pituitary adenomas.
Xu Z; Lee Vance M; Schlesinger D; Sheehan JP
Neurosurgery; 2013 Apr; 72(4):630-7; 636-7. PubMed ID: 23277375
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of higher dose stereotactic radiosurgery for functional pituitary adenomas: a preliminary report.
Grant RA; Whicker M; Lleva R; Knisely JP; Inzucchi SE; Chiang VL
World Neurosurg; 2014; 82(1-2):195-201. PubMed ID: 23385448
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of conventional radiation therapy in the management of pituitary adenoma.
Sasaki R; Murakami M; Okamoto Y; Kono K; Yoden E; Nakajima T; Nabeshima S; Kuroda Y
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1337-45. PubMed ID: 10889388
[TBL] [Abstract][Full Text] [Related]
20. Gamma Knife surgery for pituitary adenomas: factors related to radiological and endocrine outcomes.
Sheehan JP; Pouratian N; Steiner L; Laws ER; Vance ML
J Neurosurg; 2011 Feb; 114(2):303-9. PubMed ID: 20540596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
